The number of people diagnosed with asbestos caused diseases in the U.S. continues to increase. Experts believe 60,000 mesothelioma deaths will occur between 2010 and 2030.

Work related injuries harm up to 14 million people annually, with harms including traumatic brain injuries, spinal injuries, amputations, burns, and electrocutions. Around 20,000 to 60,000 workers die each year from accidents, toxins, and violence at their jobs.

Millions of consumers and workers are injured each year because of defective products. Defects can occur when a product is designed poorly, when a product is manufactured in a manner that differs from the intended design, or when the product does not contain proper warnings or instructions. Defects can occur in automobiles, pharmaceuticals, medical devices, construction equipment, toys, and other goods.

Between 1.5 and 2 million elderly reside in nursing home facilities, with studies revealing that 44% have suffered some form of abuse. Many believe the actual number of residents suffering abuse is much higher. Neglect and abuse may result in serious emotional, physical, and financial harm

Paul & Hanley’s legal team has produced some of the most notable verdicts and highest settlements in the United States. Over 500 of our clients have each obtained in excess of 1 million dollars. Over 250 have recovered multi-million dollar recoveries.

Diagnostic Clinical Trials for Mesothelioma

1. Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer

Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 08-080, NCT00722605
 

--------------------------------------------------------------------------------

2.
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Phase: Phase II
Type: Diagnostic
Status: Active
Age: 15 and over
Sponsor: Other
Protocol IDs: SP-14-0038, NCT00123773
 

--------------------------------------------------------------------------------

3.
Phase I Study of Optical Coherence Tomography of the Airway of Patients Undergoing Pneumonectomy or Lobectomy for Malignant or Benign Lung Processes

Phase: Phase I
Type: Diagnostic
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: CASE-1508, CASE1508, CASE-1508-CC483, NCT00733252
 

--------------------------------------------------------------------------------

4.
Prospective Study of Epigenetic Alterations in Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Mediastinal or Chest Wall Neoplasms, or Pulmonary Metastases from Cancers of Non-Thoracic Origin

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Tissue collection/Repository
Status: Active
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-06-C-0014, NCI-P6650, NCT00447447
 

--------------------------------------------------------------------------------

5.
Multiple Biomarkers in Undiagnosed Pleural Effusion

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: FDI-02 Pleural Effusion Study, NCT00316134
 

--------------------------------------------------------------------------------

6.
Improving Functional Outcomes in Patients With Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging

Phase: No phase specified
Type: Diagnostic, Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: 05-036, NCT00597844
 

--------------------------------------------------------------------------------

7.
Investigating the Improvement in 4D CT Images Using AV Biofeedback

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 to 86
Sponsor: Other
Protocol IDs: H-30492, H-30492, NCT00780611